Company Spotlight

Alcami

4620 Creekstone Drive
Durham, NC 27703
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile


Contract Service Directory


Pillar5 Pharma, Inc.





Company Headquarters

365 Madawaska Blvd.
Arnprior, ON K7S 0C9
Canada

Contract Service Directory

    Related Content

    • Breaking News | Capsules | Industry News | Injectables | Packaging & Tracking | Solid Dosage/Semi-solids | Vials
      Federal Equipment to Host Online Auctions

      Federal Equipment to Host Online Auctions

      Feature items include tablet presses and parts, capsule fillers, coaters and more
      12.05.17

    • Breaking News | Industry News
      Melinta Buys Infectious Disease Unit from The Medicines Company

      Melinta Buys Infectious Disease Unit from The Medicines Company

      The deal is worth well over $200M, not including future milestones and royalties
      11.29.17

    • Breaking News | Industry News
      Quotient Sciences Expands UK Footprint

      Quotient Sciences Expands UK Footprint

      Acquires UK-based CDMO Pharmaterials
      11.17.17


    • cGMP Manufacture | Information Technology
      Flexible Manufacturing Strategies and Data Integrity

      Flexible Manufacturing Strategies and Data Integrity

      Making processes integral with your data handling ability
      Emil W. Ciurczak, DoraMaxx Consulting 11.07.17

    • Drug Development | Industry News
      CPhI Report Addresses Battle Between Innovators and Biogenerics

      CPhI Report Addresses Battle Between Innovators and Biogenerics

      Regulation shifting due to increased data dependence, regulatory oversight is slowing six sigma, forecasts generic growth
      10.24.17

    • Aseptic Processing | Injectables
      Sterile Manufacturing: Future Trends and Challenges

      Sterile Manufacturing: Future Trends and Challenges

      By the middle of this century, biopharmaceuticals are set to overtake all other pharma sales
      Igor Gorsky, Concordia Valsource 10.11.17


    • cGMP Manufacture | Drug Development | Regulatory Affairs
      Contracting & Outsourcing Session Highlights and Key Takeaways

      Contracting & Outsourcing Session Highlights and Key Takeaways

      Insight into CMO Trends, Biotrends, Manufacturing Compliance, FDA Quality Agreements, and CMO Oversight
      Kristin Brooks, Contract Pharma 10.09.17

    • Breaking News | Clinical Trial Materials | Drug Development | Industry News
      Ardena Launches following Pharmavize and Crystallics Merger

      Ardena Launches following Pharmavize and Crystallics Merger

      Will offer solid-state chemistry, analytical and formulation development, and early-phase clinical supply manufacturing
      09.11.17

    • Biosimilars
      Know the Challenges of  Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best practices for a competitive market
      Jerry Martin and Michiel Ultee 09.06.17


    • Clinical Trials | Drug Development
      Cancer Trials in the New Age of Drug Development

      Cancer Trials in the New Age of Drug Development

      Insights into the rapid pace of new drug approvals and the implications for pharma/biopharma companies
      08.21.17

    • Breaking News | cGMP Manufacture | Industry News
      FDA Reauthorization Act Signed into Law

      FDA Reauthorization Act Signed into Law

      Renews four major user fee agreements between industry and FDA through FY2022
      08.21.17

    • Industry News | Inspections
      Valeant

      Valeant's Tampa Facility Receives FDA VAI Classification

      Following collaboration with FDA, issues related to a cGMP inspection are being resolved
      08.17.17


    • Breaking News | cGMP Manufacture | Drug Development | Industry News | Regulatory Affairs
      Senate Passes FDA Reauthorization Act

      Senate Passes FDA Reauthorization Act

      Aims to allow faster approval of generic drugs and modifies fee structure for various stakeholders
      08.04.17